The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
The effect of pathophysiology on pharmacokinetics in the critically ill patient — Concepts appraised by the example of antimicrobial agents
Open accessAbstract
Critically ill patients are at high risk for development of life-threatening infection leading to sepsis and multiple organ failure. Adequate antimicrobial therapy is pivotal for optimizing the chances of survival. However, efficient dosing is problematic because pathophysiological changes associated with critical illness impact on pharmacokinetics of mainly hydrophilic antimicrobials. Concentrations of hydrophilic antimicrobials may be increased because of decreased renal clearance due to acute kidney injury. Alternatively, antimicrobial concentrations may be decreased because of increased volume of distribution and augmented renal clearance provoked by systemic inflammatory response syndrome, capillary leak, decreased protein binding and administration of intravenous fluids and inotropes. Often multiple conditions that may influence pharmacokinetics are present at the same time thereby excessively complicating the prediction of adequate concentrations. In general, conditions leading to underdosing are predominant. Yet, since prediction of serum concentrations remains difficult, therapeutic drug monitoring for individual fine-tuning of antimicrobial therapy seems the way forward.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J.-L. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,618
Craig, W. A. (1998) · Clinical Infectious Diseases · doi:10.1086/516284 · Cited by 2,908
Bellomo, R., Kellum, J. A., & Ronco, C. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61454-2 · Cited by 2,598
Inadequate Antimicrobial Treatment of Infections
Kollef, M. H., Sherman, G., Ward, S., & Fraser, V. J. (1999) · Chest · doi:10.1378/chest.115.2.462 · Cited by 1,805
Vincent, J.-L. (1995) · JAMA · doi:10.1001/jama.1995.03530080055041 · Cited by 1,632
Hoste, E. A., Clermont, G., Kersten, A., Venkataraman, R., Angus, D. C., De Bacquer, D., & Kellum, J. A. (2006) · Critical Care · doi:10.1186/cc4915 · Cited by 1,471
Parrillo, J. E., Parker, M. M., Natanson, C., Suffredini, A. F., Danner, R. L., Cunnion, R. E., & Ognibene, F. P. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-3-227 · Cited by 1,179
Roberts, J. A., Paul, S. K., Akova, M., Bassetti, M., De Waele, J. J., Dimopoulos, G., Kaukonen, K.-M., Koulenti, D., Martin, C., Montravers, P., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu027 · Cited by 1,090
Self-citationPharmacokinetic issues for antibiotics in the critically ill patient
Roberts, J. A., & Lipman, J. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181961bff · Cited by 862
Self-citationIncidence and Outcomes in Acute Kidney Injury: A Comprehensive Population-Based Study
Ali, T., Khan, I., Simpson, W., Prescott, G., Townend, J., Smith, W., & MacLeod, A. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070756 · Cited by 825
Pharmacokinetics and dosage adjustment in patients with renal dysfunction
Verbeeck, R. K., & Musuamba, F. T. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0678-8 · Cited by 717
Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction
Verbeeck, R. K. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-008-0553-z · Cited by 652
The Impact of Antimicrobial Resistance on Health and Economic Outcomes
Eliopoulos, G. M., Cosgrove, S. E., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/375081 · Cited by 637
Changing epidemiology of systemic fungal infections
Richardson, M., & Lass-Flörl, C. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01978.x · Cited by 524
Kullar, R., Davis, S. L., Levine, D. P., & Rybak, M. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir124 · Cited by 463 · cited 1×
“Also for the vancomycin use in ICUpatients, insufficient drug concentrations were frequently observed and linked with poor clinical outcomes [72,73].”
BackgroundSandri, A. M., Landersdorfer, C. B., Jacob, J., Boniatti, M. M., Dalarosa, M. G., Falci, D. R., Behle, T. F., Bordinhão, R. C., Wang, J., Forrest, A., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit334 · Cited by 430
Subtherapeutic Initial β-Lactam Concentrations in Select Critically Ill Patients
Udy, A. A., Varghese, J. M., Altukroni, M., Briscoe, S., McWhinney, B. C., Ungerer, J. P., Lipman, J., & Roberts, J. A. (2012) · Chest · doi:10.1378/chest.11-1671 · Cited by 414
Self-citationEvers, L. H., Bhavsar, D., & Mailänder, P. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2010.01105.x · Cited by 400
Dulhunty, J. M., Roberts, J. A., Davis, J. S., Webb, S. A. R., Bellomo, R., Gomersall, C., Shirwadkar, C., Eastwood, G. M., Myburgh, J., Paterson, D. L., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis856 · Cited by 394
Self-citationAugmented Renal Clearance: Implications for Antibacterial Dosing in the Critically Ill
Udy, A. A., Roberts, J. A., Boots, R. J., Paterson, D. L., & Lipman, J. (2010) · Clinical Pharmacokinetics · doi:10.2165/11318140-000000000-00000 · Cited by 377
Self-citationInsufficient β-lactam concentrations in the early phase of severe sepsis and septic shock
Taccone, F. S., Laterre, P.-F., Dugernier, T., Spapen, H., Delattre, I., Wittebole, X., De Backer, D., Layeux, B., Wallemacq, P., Vincent, J.-L., et al. (2010) · Critical Care · doi:10.1186/cc9091 · Cited by 369
Early changes in organ function predict eventual survival in severe sepsis*
Levy, M. M., Macias, W. L., Vincent, J.-L., Russell, J. A., Silva, E., Trzaskoma, B., & Williams, M. D. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000182798.39709.84 · Cited by 358
Principles of antibacterial dosing in continuous renal replacement therapy
Choi, G., Gomersall, C. D., Tian, Q., Joynt, G. M., Freebairn, R., & Lipman, J. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181aab3d0 · Cited by 334
Self-citationTherapeutic drug monitoring of β-lactams in critically ill patients: proof of concept
Roberts, J. A., Ulldemolins, M., Roberts, M. S., McWhinney, B., Ungerer, J., Paterson, D. L., & Lipman, J. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.06.008 · Cited by 334
Self-citationThe Clinical Relevance of Plasma Protein Binding Changes
Roberts, J. A., Pea, F., & Lipman, J. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-012-0018-5 · Cited by 329
Self-citationPea, F., Viale, P., & Furlanut, M. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544100-00002 · Cited by 327
Self-citationChand, N., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21480 · Cited by 318
Roberts, J. A., & Lipman, J. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645080-00001 · Cited by 283
Self-citationPharmacokinetic Changes in Critical Illness
Boucher, B. A., Wood, G. C., & Swanson, J. M. (2006) · Critical Care Clinics · doi:10.1016/j.ccc.2006.02.011 · Cited by 252
Introduction to Drug Pharmacokinetics in the Critically III Patient
Smith, B. S., Yogaratnam, D., Levasseur-Franklin, K. E., Forni, A., & Fong, J. (2012) · Chest · doi:10.1378/chest.11-1396 · Cited by 230
Vancomycin AUC/MIC Ratio and 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia
Holmes, N. E., Turnidge, J. D., Munckhof, W. J., Robinson, J. O., Korman, T. M., O'Sullivan, M. V. N., Anderson, T. L., Roberts, S. A., Warren, S. J. C., Gao, W., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01485-12 · Cited by 224
Pea, F., Viale, P., Pavan, F., & Furlanut, M. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746120-00003 · Cited by 214
Self-citationEmpirical antimicrobial therapy of septic shock patients: Adequacy and impact on the outcome*
Leone, M., Bourgoin, A., Cambon, S., Dubuc, M., Albanèse, J., & Martin, C. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050298.59549.4a · Cited by 212
Implications of augmented renal clearance in critically ill patients
Udy, A. A., Roberts, J. A., & Lipman, J. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.92 · Cited by 211
Self-citationThe inflammatory response to surgery and trauma
Kohl, B. A., & Deutschman, C. S. (2006) · Current Opinion in Critical Care · doi:10.1097/01.ccx.0000235210.85073.fc · Cited by 208
Roberts, D. M., Roberts, J. A., Roberts, M. S., Liu, X., Nair, P., Cole, L., Lipman, J., & Bellomo, R. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e318241e553 · Cited by 207
Self-citationThe pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients
Joynt, G. M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.4.421 · Cited by 200
Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock
Taccone, F. S., Laterre, P.-F., Spapen, H., Dugernier, T., Delattre, I., Layeux, B., De Backer, D., Wittebole, X., Wallemacq, P., Vincent, J.-L., et al. (2010) · Critical Care · doi:10.1186/cc8945 · Cited by 199
Vital Organ Blood Flow During Hyperdynamic Sepsis
Di Giantomasso, D., May, C. N., & Bellomo, R. (2003) · Chest · doi:10.1378/chest.124.3.1053 · Cited by 198
Pea, F., & Viale, P. (2009) · Critical Care · doi:10.1186/cc7774 · Cited by 194
Self-citationReducing mortality in sepsis: new directions.
Vincent, J., Abraham, E. H., Annane, D., Bernard, G. R., Rivers, E. P., & den Berghe, G. V. (2002) · Critical Care · doi:10.1186/cc1860 · Cited by 191
Sime, F. B., Roberts, M. S., Peake, S. L., Lipman, J., & Roberts, J. A. (2012) · Annals of Intensive Care · doi:10.1186/2110-5820-2-35 · Cited by 184
Self-citationDe Paepe, P., Belpaire, F. M., & Buylaert, W. A. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241140-00002 · Cited by 181
Effects of Norepinephrine on the Renal Vasculature in Normal and Endotoxemic Dogs
BELLOMO, R., KELLUM, J. A., WISNIEWSKI, S. R., PINSKY, M. R., & Ondulik, B. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.4.9802055 · Cited by 180
Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices
Kollef, M. H., Ward, S., Sherman, G., Prentice, D., Schaiff, R., Huey, W., & Fraser, V. J. (2000) · Critical Care Medicine · doi:10.1097/00003246-200010000-00014 · Cited by 173
Blot, S. I., Cankurtaran, M., Petrović, M., Vandijck, D. M., Lizy, C., Decruyenaere, J. M. A., Danneels, C., Vandewoude, K., Piette, A., Verschraegen, G., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819da98e · Cited by 159
Self-citationAminoglycoside Volume of Distribution and Illness Severity in Critically Ill Septic Patients
Marik, P. E. (1993) · Anaesthesia and Intensive Care · doi:10.1177/0310057x9302100206 · Cited by 145
Saravolatz, L. D., Pea, F., & Viale, P. (2006) · Clinical Infectious Diseases · doi:10.1086/504383 · Cited by 137
Self-citationBlot, S. I. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01835.x · Cited by 129
Self-citationCaspofungin: A Review of its Use in the Treatment of Fungal Infections
McCormack, P. L., & Perry, C. M. (2005) · Drugs · doi:10.2165/00003495-200565140-00009 · Cited by 125
Burkhardt, O., Kumar, V., Katterwe, D., Majcher-Peszynska, J., Drewelow, B., Derendorf, H., & Welte, T. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl485 · Cited by 122
Ulldemolins, M., Roberts, J. A., Wallis, S. C., Rello, J., & Lipman, J. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq184 · Cited by 120
Self-citationDrug absorption, distribution, metabolism and excretion considerations in critically ill adults
Roberts, D. J., & Hall, R. I. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.799137 · Cited by 110
Roberts, J. A., Lipman, J., Blot, S. I., & Rello, J. (2008) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e3283021b3a · Cited by 108
Self-citationBlot, S. I., Koulenti, D., Akova, M., Bassetti, M., Waele, J. J. D., Dimοpoulos, G., Kaukonen, K., Martin, C., Montravers, P., Rello, J., et al. (2014) · Critical Care · doi:10.1186/cc13874 · Cited by 108
Self-citationJamal, J., Economou, C. J. P., Lipman, J., & Roberts, J. A. (2012) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32835685ad · Cited by 100
Self-citationGeneralized vascular permeability and pulmonary function in patients following serious trauma
Gosling, P., Sanghera, K., & Dickson, G. (1994) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-199404000-00002 · Cited by 97 · cited 1×
“This capillary leak is responsible for a fluid shift from the intravascular compartment to the interstitial space [37] leading to edema formation.”
BackgroundAntibiotic Dosing in Multiple Organ Dysfunction Syndrome
Ulldemolins, M., Roberts, J. A., Lipman, J., & Rello, J. (2011) · CHEST Journal · doi:10.1378/chest.10-2371 · Cited by 97
Self-citationUdy, A. A., Roberts, J. A., Waele, J. J. D., Paterson, D. L., & Lipman, J. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.02.010 · Cited by 88
Self-citationManagement of Invasive Candidiasis in Critically Ill Patients
Blot, S. I., & Vandewoude, K. (2004) · Drugs · doi:10.2165/00003495-200464190-00002 · Cited by 84
Self-citationPharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis
Brink, A. J., Richards, G., Schillack, V., Kiem, S., & Schentag, J. J. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.10.005 · Cited by 80
Blot, S. I., Vandewoude, K., Hoste, E. A. J., & COLARDYN, F. A. (2003) · Journal of Hospital Infection · doi:10.1053/jhin.2002.1329 · Cited by 78
Self-citationPea, F., Viale, P., Cojutti, P. G., & Furlanut, M. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01291-12 · Cited by 78
Self-citationRoberts, J. A., Joynt, G. M., Choi, G. Y. S., Gomersall, C. D., & Lipman, J. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.11.002 · Cited by 77
Self-citationMouton, J. W., Punt, N. C., & Vinks, A. A. T. M. M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01586-06 · Cited by 77
THE VALUE OF SEPSIS DEFINITIONS IN DAILY ICU-PRACTICE
Vandijck, D. M., Decruyenaere, J. M. A., & Blot, S. I. (2006) · Acta Clinica Belgica · doi:10.1179/acb.2006.037 · Cited by 69
Self-citationMolecular mechanisms of drug metabolism in the critically ill
Park, G. R. (1996) · British Journal of Anaesthesia · doi:10.1093/bja/77.1.32 · Cited by 69
Blot, S. I., Lipman, J., Roberts, D. M., & Roberts, J. A. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.01.015 · Cited by 69
Self-citationEpidemiology of infection in critically ill patients with acute renal failure
Reynvoet, E., Vandijck, D. M., Blot, S. I., Dhondt, A., Waele, J. J. D., Claus, S., Buyle, F. M., Vanholder, R. C., & Hoste, E. A. J. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a03961 · Cited by 65
Self-citationPlasma Pharmacokinetics of Antimicrobial Agents in Critically Ill Patients
Pea, F. (2013) · Current Clinical Pharmacology · doi:10.2174/157488413804810585 · Cited by 58
Self-citationHepatic Drug Metabolism in Critical Illness
McKindley, D. S., Hanes, S. D., & Boucher, B. A. (1998) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1998.tb03898.x · Cited by 53
Dimοpoulos, G., Koulenti, D., Blot, S. I., Sakr, Y. L., Anzueto, A., Spies, C., Solé‐Violán, J., Kett, D., Armaganidis, A., Martin, C., et al. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12544 · Cited by 53
Self-citationGous, A. G. S., Lipman, J., Scribante, J., Tshukutsoane, S., Hon, H., Pinder, M., Mathivha, R. L., Verhoef, L., & Staß, H. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.04.005 · Cited by 49
Self-citationCouffignal, C., Pajot, O., Laouenan, C., Burdet, C., Foucrier, A., Wolff, M., Armand-Lefèvre, L., Mentré, F., & Massias, L. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12435 · Cited by 47
Review article: volume expansion in patients with cirrhosis
Henriksen, J. H., Kiszka‐Kanowitz, M., Bendtsen, F., & Møller, S. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.16.s5.3.x · Cited by 46
Lipman, J., Udy, A. A., & Roberts, J. A. (2011) · Anaesthesia and Intensive Care · doi:10.1177/0310057x1103900602 · Cited by 46
Self-citationThe Effects of Normal and Hypertonic Saline on Regional Blood Flow and Oxygen Delivery
Wan, L., Bellomo, R., & May, C. N. (2007) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000266438.90360.62 · Cited by 40
Physiological Changes in the Critically Ill Patient with Sepsis
Hosein, F. S., Udy, A. A., & Lipman, J. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111798808248 · Cited by 39
Self-citationConil, J., Georges, B., Ruiz, S., Rival, T., Seguin, T., Cougot, P., Fourcade, O., Houin, G., & Saivin, S. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03793.x · Cited by 38
Korth-Bradley, J. M., Baird, S., Patat, A. A., Troy, S. M., Böhmer, G. M., Gleiter, C. H., Bücheler, R., & Morgan, M. Y. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010363477 · Cited by 35
Waele, J. J. D., Danneels, I., Depuydt, P. O., Decruyenaere, J. M. A., Bourgeois, M., & Hoste, E. A. J. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.12.015 · Cited by 34
Pea, F., Pavan, F., & Furlanut, M. (2008) · Clinical Pharmacokinetics · doi:10.2165/00003088-200847070-00002 · Cited by 33
Self-citationGeorges, B., Conil, J., Ruiz, S., Seguin, T., Cougot, P., Fourcade, O., Houin, G., & Saivin, S. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04117.x · Cited by 31
Cited by
Guilhaumou, R., Benaboud, S., Bennis, Y., Dahyot-Fizelier, C., Dailly, E., Gandia, P., Goutelle, S., Lefeuvre, S., Mongardon, N., Roger, C., et al. (2019) · Critical Care · doi:10.1186/s13054-019-2378-9 · Cited by 543
Opportunities and challenges in the diagnostic utility of dermal interstitial fluid
Friedel, M., Thompson, I. A. P., Kasting, G., Polsky, R., Cunningham, D., Soh, H. T., & Heikenfeld, J. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00998-9 · Cited by 360
Kollef, M. H., Nováček, M., Kivistik, Ü., Réa-Neto, Á., Shime, N., Martin-Loeches, I., Timsit, J.-F., Wunderink, R. G., Bruno, C. J., Huntington, J. A., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30403-7 · Cited by 345
From Therapeutic Drug Monitoring to Model‐Informed Precision Dosing for Antibiotics
Wicha, S. G., Märtson, A., Nielsen, E. I., Koch, B. C. P., Friberg, L. E., Alffenaar, J., Minichmayr, I. K., & the International Society of Anti‐Infective Pharmacology (ISAP), T. P. S. G. O. T. E. S. O. C. M. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2202 · Cited by 322
Applications of the pharmacokinetic/pharmacodynamic (PK/PD) analysis of antimicrobial agents
Asín-Prieto, E., Rodríguez-Gascón, A., & Isla, A. (2015) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2015.02.001 · Cited by 262
Metadata
- Authors
- Blot, S. I., Pea, F., & Lipman, J.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2014-11
- Volume
- 77
- Pages
- 3-11
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2093073135
- Cited by
- 444
- References
- 87
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.